€1.52
4.70% today
Brüssel, Feb 28, 05:39 pm CET
ISIN
BE0974340722
Symbol
SEQUA
Sector

Sequana Medical Target price 2025 - Analyst rating & recommendation

Sequana Medical Classifications & Recommendation:

Buy
67%
Hold
33%

Sequana Medical Price Target

Target Price €4.23
Price €1.52
Potential
Number of Estimates 4
4 Analysts have issued a price target Sequana Medical 2026 . The average Sequana Medical target price is €4.23. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 3 analysts: 2 Analysts recommend Sequana Medical to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sequana Medical stock has an average upside potential 2026 of . Most analysts recommend the Sequana Medical stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Revenue Million € 0.71 0.24
22.83% 66.11%
EBITDA Margin -4,097.18% -6,190.82%
34.72% 51.10%

4 Analysts have issued a sales forecast Sequana Medical 2024 . The average Sequana Medical sales estimate is

€241k
Unlock
. This is
44.05% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€463k 7.56%
Unlock
, the lowest is
€0.0 100.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 €710k 22.83%
2024
€241k 66.11%
Unlock
2025
€1.9m 690.32%
Unlock
2026
€12.7m 568.77%
Unlock
2027
€28.5m 124.44%
Unlock

3 Analysts have issued an Sequana Medical EBITDA forecast 2024. The average Sequana Medical EBITDA estimate is

€-14.9m
Unlock
. This is
34.03% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€-13.2m 41.54%
Unlock
, the lowest is
€-17.7m 21.61%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 €-29.1m 3.97%
2024
€-14.9m 48.79%
Unlock
2025
€-12.3m 17.44%
Unlock
2026
€-16.5m 33.91%
Unlock
2027
€-16.8m 2.20%
Unlock

EBITDA Margin

2023 -4,097.18% 34.72%
2024
-6,190.82% 51.10%
Unlock
2025
-646.82% 89.55%
Unlock
2026
-129.51% 79.98%
Unlock
2027
-58.98% 54.46%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
EV/Sales 422.98

Based on analysts' sales estimates for 2024, the Sequana Medical stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

422.98
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
347.43
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 236.70 87.19%
2024
422.98 78.70%
Unlock
2025
53.53 87.35%
Unlock
2026
8.00 85.05%
Unlock
2027
3.57 55.44%
Unlock

P/S ratio

Current 194.42 84.44%
2024
347.43 78.70%
Unlock
2025
43.96 87.35%
Unlock
2026
6.57 85.05%
Unlock
2027
2.93 55.44%
Unlock

Current Sequana Medical Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
KBC SECURITIES Locked ➜ Locked Locked Jan 06 2025
H.C. WAINWRIGHT & CO., LLC Locked ➜ Locked Locked Dec 23 2024
DEGROOF PETERCAM Locked ➜ Locked Locked Dec 22 2024
Analyst Rating Date
Locked
KBC SECURITIES: Locked ➜ Locked
Jan 06 2025
Locked
H.C. WAINWRIGHT & CO., LLC: Locked ➜ Locked
Dec 23 2024
Locked
DEGROOF PETERCAM: Locked ➜ Locked
Dec 22 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today